News
Cigna Sets $200 Monthly Limit For Weight-Loss Drug Users
Digest more
Zacks Investment Research on MSN4h
CI's Unit Unveils Offering to Expand Access to GLP-1 MedicationsThe health services arm of The Cigna Group CI, Evernorth, recently introduced a pharmacy benefit offering designed to enhance ...
21hon MSN
The Cigna Group (NYSE:CI)’s Evernorth division has announced a new deal with Novo Nordisk and Eli Lilly that will limit ...
Cigna's Evernorth is rolling out a new pharmacy benefit management program that caps members' monthly cost for key GLP-1 ...
Cigna subsidiary Evernorth Health Services will automate prior authorizations for GLP-1 weight-loss drugs under a new program ...
The agreements cap monthly out-of-pocket costs for Zepbound and Wegovy at $200 and more deeply discount the drugs for ...
While the stock may appear attractively Health insurance company Cigna (NYSE:CI) beat Wall Street’s revenue expectations in Q1 CY2025, with sales up 14.4% year on year to $65.5 billion.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback